Erschienen: 28.09.2015 Abbildung von Schön | Pharma M&A versus alliances and its underlying value drivers | 2015 | Are M&A or alliances the right... | 15

Schön

Pharma M&A versus alliances and its underlying value drivers

Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

2015. Buch. 201 S. Hardcover

Peter Lang. ISBN 978-3-631-66381-3

Format (B x L): 14,8 x 21 cm

Gewicht: 360 g

In englischer Sprache

Das Werk ist Teil der Reihe: Corporate Finance and Governance; 15

Produktbeschreibung

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Autoren

  • Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...